Could it bind a therapeutic substance that the device is meant to deliver?
Last reviewed: .
Could it bind a therapeutic substance that the device is meant to deliver?
The company publishes no result for that exposure.
The company publishes no binding study. What it states about the mechanism is that NanoFlashing™ attracts negatively charged particles through electrostatic attraction, and that the filter captures airborne particles mechanically and by electrostatic attraction. The Terms of Use state: “A reported result describes only what the identified test found.” The Terms of Use state that, as of their effective date, the Water, Textiles, Food packaging, and Medical devices chapters describe Research Applications, and that they do not describe finished products currently available from C-POLAR for those uses.
Source: C-POLAR — NanoFlashing™, https://cpolar.tech/nanoflashing/; Statement of Classification for the NanoFlashing™ Air Filter, section 2.5, issued by NF Technical Products Inc.; C-POLAR — Validation, https://cpolar.tech/validation/; C-POLAR — Terms of Use, sections 3 and 4, https://cpolar.tech/terms/.
Reviewed on .
Sources
- C-POLAR — NanoFlashing™
- Statement of Classification for the NanoFlashing™ Air Filter, section 2.5, issued by NF Technical Products Inc.
- C-POLAR — Validation
- C-POLAR — Terms of Use, sections 3 and 4